Provectus Comments on 2006 Q3 Results
14th Nov 2006, 15:17 GMT
More Clinical Progress Continues for Treatment of Metastatic Melanoma in Third Quarter
Provectus Comments on 2006 Q3 Results related news:
- Provectus Comments on 2006 Third Quarter Results — PR Newswire: All Releases
- Stratagene Reports Q3 Results — Laboratory News from StratCenter.com
- eGene Reports a Profitable Quarter Result and Revenue Increases 273% in Q3 2006 Compared to Q3 2005 — Operations-Related News from StratCenter.com
- Cardiogenesis Reports Q3 2006 Results — Surgery News from StratCenter.com
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Chelsea Therapeutics Reports Q3 2006 Results — Operations-Related News from StratCenter.com
- Adherex Reports Q3 2006 Financial Results — Radiology News from StratCenter.com
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- Nymox Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com